EUVIMEDEUVIMED entdecken
Crossref

HBV PreS/S gene mutations in patients with chronic hepatitis B

Bülent Çakal, Bilger Çavuş, Alp Atasoy, Mesut Bulakçı, Mine Güllüoğlu, Filiz Akyüz

Archives of Virology · 2026-08 · 171 (8)

DOI: 10.1007/s00705-026-06685-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Virology, online erschienen am 25.07.2026. Verfasst von Bülent Çakal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. bulentcakal@yahoo.com. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B virus, Hepatitis B Surface Antigens, Mutation. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in the hepatitis B virus (HBV) PreS/S gene have been suggested to contribute to the development of progressive liver disease. This study aimed to evaluate the association between HBV PreS/S variations and liver histopathology in patients with chronic hepatitis B. A total of 109 patients under clinical follow-up for chronic hepatitis B were included. The HBV PreS/S gene was amplified by PCR and sequenced using the Sanger method. Amino acid substitutions, nonsense mutations, and deletions were analyzed in relation to liver fibrosis stage. Overall, 58 of 389 amino acid sites (14.9%) in the HBV PreS/S gene showed substitutions, with the highest mutation rate observed in the PreS2 region (27.27%). Mutations L54P (PreS1), F130L/S (PreS2), and S207R/N/I/T and I208T (S gene) were significantly more frequent in patients with advanced fibrosis (F ≥ 3) (p < 0.05). Multivariable analysis identified S207R/N/I/T as an independent risk factor for liver fibrosis. Patients with PreS2 mutations had higher fibrosis scores (p < 0.05). The S207R/N/I/T mutation in the C-terminal region of the HBV S protein is independently associated with liver fibrosis, while PreS2 mutations may contribute to fibrosis progression in chronic hepatitis B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis B virusHepatitis B Surface AntigensMutationHumansFemaleMaleLiver CirrhosisAdultMiddle AgedAmino Acid SubstitutionLiverDNA, Viral

Substanzen

Hepatitis B Surface AntigensDNA, Viral

Autor:innen und Institutionen

  • Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. bulentcakal@yahoo.com.
  • Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, Topkapı Mahallesi, Turgut Özal Caddesi No:118, Fatih/İstanbul, 34093, Turkey. bulentcakal@yahoo.com.
  • Division of Gastroenterohepatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Çakal, B., Çavuş, B., Atasoy, A., Bulakçı, M., Güllüoğlu, M., & Akyüz, F. (2026). HBV PreS/S gene mutations in patients with chronic hepatitis B. Archives of Virology, 171(8). https://doi.org/10.1007/s00705-026-06685-3

Vancouver

Çakal B, Çavuş B, Atasoy A, Bulakçı M, Güllüoğlu M, Akyüz F. HBV PreS/S gene mutations in patients with chronic hepatitis B. Archives of Virology. 2026;171(8). doi:10.1007/s00705-026-06685-3

BibTeX
@article{akal2026,
  author = {Çakal, Bülent and Çavuş, Bilger and Atasoy, Alp and Bulakçı, Mesut and Güllüoğlu, Mine and Akyüz, Filiz},
  title = {HBV PreS/S gene mutations in patients with chronic hepatitis B},
  journal = {Archives of Virology},
  year = {2026},
  volume = {171},
  number = {8},
  doi = {10.1007/s00705-026-06685-3}
}
Kostenlos starten →